An evidence-based systematic review of the off-label uses of lisinopril

about

An evidence-based systematic review of the off-label uses of lisinopril

Item

http://www.wikidata.org/entity/Q57487671

description

im November 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 11 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

An evidence-based systematic review of the off-label uses of lisinopril

@en

An evidence-based systematic review of the off-label uses of lisinopril

@nl

type

Item

label

An evidence-based systematic review of the off-label uses of lisinopril

@en

An evidence-based systematic review of the off-label uses of lisinopril

@nl

prefLabel

An evidence-based systematic review of the off-label uses of lisinopril

@en

An evidence-based systematic review of the off-label uses of lisinopril

@nl

P1476

An evidence-based systematic review of the off-label uses of lisinopril

@en

P2093

Amir Azarpazhooh

http://www.w3.org/2001/XMLSchema#string

Hossein Babaei

http://www.w3.org/2001/XMLSchema#string

Morteza Ghojazadeh

http://www.w3.org/2001/XMLSchema#string

Neda Parnianfard

http://www.w3.org/2001/XMLSchema#string

P2860

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients

Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophy.

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.

An approach to the patient with hirsutism.

Off-label prescribing among office-based physicians.

Regulating off-label drug use--rethinking the role of the FDA.

Prioritizing future research on off-label prescribing: results of a quantitative evaluation

P304

2502-2521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13705

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nafiseh Vahed

Sydney C W Tang

Seyyed-Reza Sadat-Ebrahimi

P577

2018-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29971804

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6177695

http://www.w3.org/2001/XMLSchema#string